Phase I Study of DP-b99

Completed

Phase 1 Results

Summary of Purpose

To evaluate the safety and efficacy of single escalating doses of DP-b99 after intravenous administration to healthy male volunteers.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 8 July 2002.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • D-Pharm, Rehovot, Israel

Trial Design

Placebo-controlled, randomized, dose-escalating study.

Contacts

Not available